Episode
Peter Mantas on the Coiled Spring of Biotech: FDA Shakeups, uniQure's Breakthrough, and AI Drug Discovery
- Published
- May 13, 2026
- Duration seconds
- 3242
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/this-week-in-intelligent-investing-744474/episodes/peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqure-s-breakthrough-and-ai-drug-discovery/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/this-week-in-intelligent-investing-744474/peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqure-s-breakthrough-and-ai-drug-discovery.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of This Week in Intelligent Investing, hosts John Mihaljevic and Elliot Turner welcome Peter Mantas, General Partner and Chief Investment Officer at Logos LP. Recorded on May 12, 2026, the discussion dives deep into the rapidly shifting landscape of biotechnology and life sciences investing.